Immunomedics, Inc. (IMMU) Appoints Richard L. Sherman to Board of Directors
8/21/2013 9:11:02 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
MORRIS PLAINS, N.J., Aug. 20, 2013 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that Richard L. Sherman, J.D., has been appointed to the Company's Board of Directors.
Help employers find you! Check out all the jobs and post your resume.